The Oncosearch | Oncotarget

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, Shu-Hui Liu

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33446-33458

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Yudong Wang, Zhijie Wang, Sarina Piha-Paul, Filip Janku, Vivek Subbiah, Naiyi Shi, Kenneth Hess, Russell Broaddus, Baoen Shan, Aung Naing, David Hong, Apostolia M. Tsimberidou, Daniel Karp, Charles Lu, Vali Papadimitrakopoulou, John Heymach, Funda Meric-Bernstam, Siqing Fu

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33258-33270

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Eduard Teixidor, Elia Sais, Carmen Amalia VÃ¡squez, Walter Carbajal, Alejandro HernÃ¡ndez, Gloria SÃ¡nchez, Angel Izquierdo, Sara Verdura, Javier A. MenÃ©ndez, Joaquim Bosch-Barrera

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 33043-33049

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

Shuhei Suzuki, Masashi Okada, Hiroyuki Takeda, Kenta Kuramoto, Tomomi Sanomachi, Keita Togashi, Shizuka Seino, Masahiro Yamamoto, Takashi Yoshioka, Chifumi Kitanaka

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32667-32679

The assessment of correlation and prognosis among ¹⁸F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients Research Paper

Hayato Kaida, Koichi Azuma, Akihiko Kawahara, Eiji Sadashima, Satoshi Hattori, Shinzo Takamori, Jun Akiba, Kiminori Fujimoto, Axel Rominger, Takamichi Murakami, Kazunari Ishii, Masatoshi Ishibashi

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 31971-31984

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer Priority Research Paper

Eric Haines, Ting Chen, Naveen Kommajosyula, Zhao Chen, Grit S. Herter-Sprie, Liam Cornell, Kwok-Kin Wong, Geoffrey I. Shapiro

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31572-31589

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 Research Paper

Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, Marcella Marconi, Marco Sommaggio, Matteo Brunelli, Guido Martignoni, George J. Netto, Mohammad O. Hoque, Francesca Moretta, Maria Cristina Mingari, Maria Cristina Pegoraro, Francesca Romana Mariotti, Paola Vacca, Lorenzo Moretta, Giuseppe Bogina

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30465-30471

Heuristic value-based framework for lung cancer decision-making Research Paper

Isa Mambetsariev, Rebecca Pharaon, Arin Nam, Kevin Knopf, Benjamin Djulbegovic, Victoria M. Villaflor, Everett E. Vokes, Ravi Salgia

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29877-29891

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

Liqin Du, Zhenze Zhao, Milind Suraokar, Spencer S. Shelton, Xiuye Ma, Tzu-Hung Hsiao, John D. Minna, Ignacio Wistuba, Alexander Pertsemlidis

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29601-29618

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Vino T. Cheriyan, Hashem Alsaab, Sreeja Sekhar, Jaganathan Venkatesh, Arindam Mondal, Imran Vhora, Samaresh Sau, Magesh Muthu, Lisa A. Polin, Edi Levi, Gerold Bepler, Arun K. Iyer, Mandip Singh, Arun K. Rishi

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29680-29697

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Eiki Ichihara, Katsuyuki Hotta, Toshio Kubo, Tsukasa Higashionna, Kiichiro Ninomiya, Kadoaki Ohashi, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura

Published Jun 29, 2018 · Vol. 9, No. 50 · pp. 29525-29531

Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines Research Paper

Mira Y. GÃ¶kyildirim, Ulrich Grandel, Katja Hattar, Gabriele Dahlem, Elena Schuetz, Florian H. Leinberger, Fabian Eberle, Ulf Sibelius, Friedrich Grimminger, Werner Seeger, Rita Engenhart-Cabillic, Ekkehard Dikomey, Florentine S.B. Subtil

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28976-28988

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer Research Paper

Alfiah Noor, Ijeoma Adaku Umelo, Peter Kronenberger, Philippe Giron, Elly De Vlieghere, Olivier De Wever, Erik Teugels, Jacques De GrÃ¨ve

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28731-28744

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Jacky Yu-Chung Li, James Chung-Man Ho, Kam-Hung Wong

Published Jun 15, 2018 · Vol. 9, No. 46 · pp. 27929-27939

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer Research Paper

Akito Hata, Daijiro Harada, Chiyuki Okuda, Reiko Kaji, Yoshio Masuda, Yoshika Takechi, Toshiyuki Kozuki, Naoyuki Nogami, Nobuyuki Katakami

Published Jun 12, 2018 · Vol. 9, No. 45 · pp. 27789-27796

Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors Research Paper

Ewa Rupniewska, Rajat Roy, Francesco A. Mauri, Xinxue Liu, Maciej Kaliszczak, Guido Bellezza, Lucio Cagini, Mattia Barbareschi, Stefano Ferrero, Anna M. Tommasi, Eric Aboagye, Michael J. Seckl, Olivier E. Pardo

Published Jun 8, 2018 · Vol. 9, No. 44 · pp. 27346-27362

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelialâ€“mesenchymal transition is critical in conquering ALK-positive lung cancer Research Paper

Shinji Nakamichi, Masahiro Seike, Akihiko Miyanaga, Mika Chiba, Fenfei Zou, Akiko Takahashi, Arimi Ishikawa, Shinobu Kunugi, Rintaro Noro, Kaoru Kubota, Akihiko Gemma

Published Jun 5, 2018 · Vol. 9, No. 43 · pp. 27242-27255

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment Research Paper

Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, Linea Melchior, Jens Benn SÃ¸rensen

Published May 25, 2018 · Vol. 9, No. 40 · pp. 26195-26208

Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases Research Paper

George D. Wilson, Matthew D. Johnson, Samreen Ahmed, Paola Yumpo Cardenas, Inga S. Grills, Bryan J. Thibodeau

Published May 25, 2018 · Vol. 9, No. 40 · pp. 25957-25970

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis Meta-Analysis

Ross A. Soo, Zhaojin Chen, Rebecca Siew Yan Teng, Hon-Lyn Tan, Barry Iacopetta, Bee Choo Tai, Richie Soong

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24801-24820

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

The assessment of correlation and prognosis among ¹⁸F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients Research Paper

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer Priority Research Paper

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 Research Paper

Heuristic value-based framework for lung cancer decision-making Research Paper

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines Research Paper

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer Research Paper

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer Research Paper

Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors Research Paper

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelialâ€“mesenchymal transition is critical in conquering ALK-positive lung cancer Research Paper

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment Research Paper

Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases Research Paper

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis Meta-Analysis

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

The assessment of correlation and prognosis among 18F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients Research Paper

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer Priority Research Paper

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 Research Paper

Heuristic value-based framework for lung cancer decision-making Research Paper

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines Research Paper

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer Research Paper

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer Research Paper

Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors Research Paper

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelialâ€“mesenchymal transition is critical in conquering ALK-positive lung cancer Research Paper

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment Research Paper

Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases Research Paper

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis Meta-Analysis

The assessment of correlation and prognosis among ¹⁸F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients Research Paper